Table 4.

Adjusted odds ratios of response derived from GEE model of response versus non-response for multiple symptoms.

Covariates	Symptom	Level	Ref. Level	Adjusted odds ratio (95% CI)	Chi-square p-value
Trial arm	Cough	ATSM	NASM	6.91 (1.89, 25.22)	<0.01
	Anxiety			2.65 (1.21,5.84)	0.02
	Poor Appetite			2.44 (1.19, 5.03)	0.02
	Depression			2.16 (1.11, 4.19)	0.02
	Dry Mouth			1.91 (0.78, 4.69)	0.16
	Constipation			1.85 (0.84, 4.06)	0.12
	Fatigue			1.75 (1.09, 2.80)	0.02
	Diarrhea			1.72 (0.57, 5.23)	0.34
	Peripheral Neuropathy			1.66 (0.80, 3.42)	0.17
	Dyspnea			1.24 (0.61, 2.51)	0.56
	Nausea/Vomiting			1.01 (0.44, 2.34)	0.98
	Difficulty Remembering			0.96 (0.53, 1.76)	0.91
	Insomnia			0.91 (0.44, 1.85)	0.79
	Weakness			0.64 (0.37, 1.10)	0.11
	Pain			0.48 (0.26, 0.88)	0.02
Number of comorbid conditions		3 and above	Less than 3	0.58 (0.44, 0.76)	<0.01
Number of symptoms that reached moderate or severe		8 and above	Less than 8	0.60 (0.46, 0.79)	<0.01
Onset time	Nausea/Vomiting	1st contact	2nd or later contact	1.67 (0.72, 3.86)	0.23
	Dry Mouth			1.51 (0.75, 3.05)	0.25
	Insomnia			1.50 (0.83, 2.70)	0.18
	Constipation			1.40 (0.75, 2.62)	0.29
	Weakness			1.27 (0.81, 2.00)	0.30
	Diarrhea			1.26 (0.47, 3.39)	0.64
	Poor Appetite			1.15 (0.67, 1.96)	0.62
	Anxiety			1.05 (0.58, 1.88)	0.88
	Pain			0.95 (0.56, 1.59)	0.84
	Cough			0.79 (0.39, 1.58)	0.50
	Dyspnea			0.78 (0.43, 1.41)	0.41
	Depression			0.73 (0.44, 1.22)	0.23
	Difficulty Remembering			0.59 (0.37, 0.93)	0.02
	Peripheral Neuropathy			0.44 (0.22, 0.86)	0.02
	Fatigue			0.28 (0.20, 0.40)	<0.01